SCHEMBL19976734

SCHEMBL19976734

CC1(CN/C(=N/C(=O)c2ccc(F)c(F)c2)Nc2n[nH]c3ccccc23)COC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 14/20 0.36
MAPK8 P45983 10/20 0.36
HDAC6 Q9UBN7 1/20 0.36
NTRK1 P04629 1/20 0.36
NAMPT P43490 1/20 0.35
ABL1 P00519 1/20 0.35
BCR P11274 1/20 0.35
PLK4 O00444 1/20 0.34
MAPK13 O15264 1/20 0.34
DAPK3 O43293 1/20 0.34
PRKD3 O94806 1/20 0.34
MAP4K4 O95819 1/20 0.34
CDK1 P06493 1/20 0.34
PIM1 P11309 1/20 0.34
CDK2 P24941 1/20 0.34
MARK3 P27448 1/20 0.34
FLT4 P35916 1/20 0.34
MAPK9 P45984 1/20 0.34
CDK8 P49336 1/20 0.34
CLK2 P49760 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976762 0.88 MAP2K4 (0.40) MAPK10MAPK8HDAC6NTRK1GSK3B
SCHEMBL19976846 0.82 KDM4E (0.42) MAPK10MAPK8HDAC6ABL1BCR
SCHEMBL19976757 0.82 HDAC6 (0.39) MAPK10MAPK8HDAC6ABL1BCR
SCHEMBL19976731 0.79 MAPK1 (0.42) MAPK8HDAC6NTRK1ABL1BCR
SCHEMBL19976730 0.79 HDAC6 (0.41) MAPK10MAPK8HDAC6PLK4MAPK13
SCHEMBL18558609 0.78 HDAC3 (0.38) HDAC6NTRK1NAMPT
SCHEMBL19976866 0.73 DYRK1A (0.42) MAPK8NTRK1PLK4MAPK13DAPK3
SCHEMBL19976776 0.72 GSK3B (0.48) HDAC6GSK3BDYRK1AMAPK1
SCHEMBL19976886 0.72 GSK3B (0.43) HDAC6GSK3BMAPK1
SCHEMBL19976857 0.71 MAPK1 (0.35) MAPK8HDAC6ABL1BCRPLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed